Abbott Laboratories Surges on 2026 Profit Guidance Raise

Abbott Laboratories shares surged the most in 24 years after the company raised its 2026 profit guidance. The increase followed a stronger-than-expected second quarter driven by improved performance across most business lines. The guidance raise boosted investor confidence, marking a significant milestone for the healthcare company.